USPTO 2015–2025 USPTO PatentsView US Corporation

Bonutti Research, Inc.

USPTO PatentsView assignee record - 27 granted patents across 5 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

RSS updates for this company

The verdict

According to USPTO PatentsView, Bonutti ranks #11,190 of 49,997 tracked US assignees by granted-patent volume, with 27 patents across 5 technology areas.

#11,190
of 49,997 US assignees by volume
39th percentile
by Innovation Score (31.9/100)
15.2
avg claims per patent
-71%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R11190 · US Corporation #11,190 · 27 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

  • GRANTS-SMALL 27 grants
  • UPPER-Q #11,190/49,997
  • PHOTO-FINISH Bausch + Lomb Ireland
  • CPC-NARROW A61F · 5 areas
  • INNOV-THIN 31.9/100
  • CLAIMS-RICH 15.2 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DROP -71% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Bausch + Lomb Ireland Limited (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Bonutti’s 31.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Bonutti

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Bonutti's Innovation Score is 31.9/100 (39th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Bonutti?

Each dot is one of Bonutti’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Bonutti’s own 15.2 claims/patent is at or below the 16.7 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Bonutti vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 26.92727.1 0102030 Granted patents (volume) Avg claims / patent Bitmain Technologies Inc. - 27, 8.93BitmainBLÜCHER GMBH - 27, 16.74BLÜCHERBmts Technology GmbH & Co. KG - 27, 18.59Bmts Technology &…Bone Foam, Inc. - 27, 9.96Bone FoamBTL Medical Technologies s.r.o. - 27, 28.52BTL Medical s r oBuccellati Holding Italia S.P.A. - 27, 1Buccellati Holdin…Bwxt Nuclear Energy, Inc. - 27, 20.3Bwxt Nuclear Ener…Bausch + Lomb Ireland Limited - 27, 18Bausch + Lomb Ire…Bonutti Research, Inc. - 27, 15.19Bonutti Research
Bonutti vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Bonutti's grants concentrate

Bonutti Research, Inc. is a focused PatentsView assignee: 5 CPC subclasses with 85.2% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2016 (10 grants) versus a trough of 1 in 2021. By volume, Bonutti sits between Bitmain Technologies Inc. and Bausch + Lomb Ireland Limited.

Bonutti's three-year grant acceleration

Bonutti Research, Inc. shows 3 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Bonutti's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Bonutti holds 27 patents at rank #11,182, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Bonutti

By rank, the assignees closest to #11,182 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Bonutti's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Bonutti, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Bonutti ranks #288 of 3,082 assignees by patent count in that subclass.

Bonutti's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

32 39th percentile higher than 39% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

024681012 2015201620172018201920202021202220232024 1
USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Bonutti Research, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 2 7.4%
2016 10 37.0%
2017 3 11.1%
2018 3 11.1%
2019 3 11.1%
2020 2 7.4%
2021 1 3.7%
2022 1 3.7%
2023 1 3.7%
2024 1 3.7%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Bonutti Research, Inc.'s patent record in context - here's where to go next.

  • Bonutti Research, Inc.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 85.2% of its portfolio - see every assignee active in that class. Explore A61F
  • Ranked #11,190 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Bonutti Research, Inc. against Bitmain Technologies Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 31.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.